Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.86B | 6.86B | 12.74B | 4.96B | 2.78B | 2.72B |
Gross Profit | 3.48B | 3.48B | 7.28B | 3.92B | 2.14B | 2.04B |
EBITDA | 3.50B | 3.50B | 7.95B | 4.27B | 2.36B | 1.96B |
Net Income | 65.55M | 65.78M | 4.16B | 1.82B | 906.87M | 1.06B |
Balance Sheet | ||||||
Total Assets | 77.65B | 77.65B | 72.60B | 56.12B | 48.51B | 36.50B |
Cash, Cash Equivalents and Short-Term Investments | 3.96B | 3.96B | 2.58B | 3.12B | 1.36B | 1.98B |
Total Debt | 50.88B | 50.88B | 45.22B | 34.49B | 30.05B | 19.47B |
Total Liabilities | 58.61B | 58.61B | 53.46B | 40.50B | 34.50B | 22.62B |
Stockholders Equity | 19.04B | 19.04B | 19.15B | 15.62B | 14.01B | 13.88B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -5.54B | -3.24B | -4.99B | -13.43B | -7.70B |
Operating Cash Flow | 0.00 | 553.47M | 8.60B | 3.48B | -2.43B | 219.61M |
Investing Cash Flow | 0.00 | -4.92B | -14.56B | -5.89B | -9.19B | -5.46B |
Financing Cash Flow | 0.00 | 5.49B | 5.31B | 4.23B | 10.78B | 6.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥43.73B | 8.79 | 3.39% | 7.19% | 45.73% | ||
78 Outperform | ¥36.24B | 10.13 | 2.30% | 32.53% | 182.70% | ||
77 Outperform | ¥31.41B | 13.03 | 3.17% | 2.04% | -11.59% | ||
76 Outperform | ¥26.78B | 10.60 | 4.56% | 5.49% | 17.69% | ||
75 Outperform | ¥40.80B | 13.68 | 2.34% | -0.46% | -25.32% | ||
61 Neutral | $36.05B | 6.66 | -10.10% | 1.86% | 8.68% | -8.81% | |
58 Neutral | ¥38.22B | 531.48 | 5.29% | -61.35% | -104.58% |